The Continuum of MGUS and Smoldering Myeloma: When to Treat?
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Outline the biological insights and clinical management of MGUS/smoldering MM
C. Ola Landgren, MD, PhD
Memorial Sloan Kettering Cancer Center
- 0.50 Participation
- 0.44 Nurse
- 0.50 Pharmacist
- 0.50 Physician